(Q50857490)
Statements
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3 (English)
Belshe RB
Gorse GJ
Francis DP
Gregory T
Migasena S
Kitayaporn D
Pitisuttitham P
Matthews T
Schwartz DH
1 October 1998